ISOPP CAPhO Symposium 2025

Immunotherapy Masterclass

Visit the Registration page for information on fees and how to register. 

Monday, April 7, 2025, 08:30-12:30
Victoria Conference Centre
Available to ISOPP members. Not a member? Join here. 

It is recognized that there is an essential role for the oncology pharmacist in improving patient outcomes for patients receiving immunotherapy with immune checkpoint inhibitors and CAR T-cell therapy. This program will support oncology pharmacists in developing a clinical understanding of immunotherapy and the essential role that pharmacists play at the forefront of therapy management.

Learning Objectives: 
By the end of this masterclass, the participant will be able to: 

1. Review and discuss key immunotherapy concepts and the mechanism of action of immune checkpoint inhibitors, bispecific antibodies and CAR T-cell therapy
2. Describe the fundamentals of care with immune checkpoint inhibitors including dosing, novel routes of administration, adverse effects and management of patients on treatment
3. Describe the fundamentals of care with bispecific antibodies including dosing, adverse effects and management of patients on treatment
4. Describe the fundamentals of care with CAR T-cell therapy including pharmacokinetics, adverse effects and management of patients on treatment
5. Using case studies, discuss the management of patients on immunotherapy

Program (subject to change)

Facilitator

• Lynne Nakashima, BC Cancer, Canada 

Presenters

• Esin Aysel Kandemir, Carl von Ossietzky Universität Oldenburg, Germany
• Lynne Nakashima, BC Cancer, Canada 
• Cameron Roessner, Arthur J.E. Child Comprehensive Cancer Centre, Canada

Expert Support Tutors

• Himanshu Patel, Methapharm Inc, Canada
• Tiffany Chan, Great Western Hospital, UK
• Evelyn Handel, National Comprehensive Cancer Network, USA